|
RU2481791C2
|
|
Method of assessing efficiency of immunomodulator imunofan application in experimental cholera
|
|
RU2473558C1
|
|
Protein causeing cell autoagglutination property of plague microbes, and method for producing it
|
|
RU2473697C2
|
|
Method for differentiation of strains of vibrio cholerae serogroup 0139 by alkyl sulphate activity
|
|
RU2460802C1
|
|
Method for identifying yersinia enterocolitica
|
|
RU2451752C1
|
|
Method for differentiating francisella tularensis subsp mediasiatica bacteria
|
|
RU2430376C1
|
|
Method of obtaining pseudotuberculosis antigen polymer diagnosticum
|
|
RU2425875C1
|
|
CULTIVATED HYBRID CELL STRAIN OF Mus Musculus L ANIMALS - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC TO LPS OF CHOLERA VIBRIO 0139 SEROGROUP
|
|
RU2425872C1
|
|
Yersinia enterocolitica BACTERIA STRAIN USED AS INDICATOR CULTURE FOR DETECTING MODERATE BACTERIOPHAGES OF LYSOGENIC STRAINS OF O1, O3, O12 SEROVARS
|
|
RU2425874C1
|
|
CULTIVATED HYBRID CELL STRAIN OF Mus musculus L ANIMALS - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC TO O-ANTIGENE OF CHOLERA VIBRIO SEROGROUP O1
|
|
RU2422535C1
|
|
METHOD FOR Yersinia pestis Yersinia pseudotuberculosis STRAIN IDENTIFICATION
|
|
RU2422520C1
|
|
Method of producing and recording marked bacteriophages in cholera germ model
|
|
RU2404251C1
|
|
Method of identification and intrageneric differentiation of strains of species yersinia pestis
|
|
RU2417376C2
|
|
METHOD FOR ASSESSING CLINICAL EFFICACY OF ANTIBACTERIAL PREPARATIONS FOR SPECIAL DANGER INFECTIOUS AGENTS Francisella tularensis AND Brucella spp
|
